Clinical Trial Update: Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing dose effects of estradiol with progesterone on inflammatory markers in healthy symptomatic menopausal women. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• ESTRADIOL (Estradiol)
• PROGESTERONE (Progesterone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Healthy Symptomatic Menopausal Women | Phase 3 | Status: TERMINATED